In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Akubio Ltd.

Latest From Akubio Ltd.

Akubio Ltd.

Founded in 2001, Akubio Ltd. is one company seeking to tap the commercial potential of acoustic detection technology in drug discovery and development, as well as diagnostics. The company's Rupture Event Scanning (REVS) and Resonant Acoustic Profiling (RAP) platforms can be used to detect not only large molecules like viruses and bacterial cells, but also small molecule drugs, proteins or oligonucleotides. As well as being simpler, faster and cheaper than other detection technologies such as PCR and ELISA, Akubio's platforms can also generate information on the binding affinities and kinetics of molecules' interactions with their receptors.

Europe Strategy

The University of Cambridge Technology Transfer Office

After years of technology transfer underfunding, Cambridge University is now one of the most successful technology transfer institutes in the UK, holding equity stakes in more than 30 spin-outs and over 220 different patent families.

Europe Deals
See All

Company Information

  • Industry
  • Biotechnology
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics